Form 8-K - Current report:
SEC Accession No. 0001171843-26-003793
Filing Date
2026-05-29
Accepted
2026-05-29 16:15:18
Documents
12
Period of Report
2026-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052226.htm   iXBRL 8-K 36156
2 EXHIBIT 10.1 exh_101.htm EX-10.1 7225
  Complete submission text file 0001171843-26-003793.txt   210130

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE edsa-20260527_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE edsa-20260527_pre.xml EX-101.PRE 22366
5 XBRL SCHEMA FILE edsa-20260527.xsd EX-101.SCH 3026
16 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052226_htm.xml XML 3031
Mailing Address 100 SPY COURT MARKHAM Ontario, Canada
Business Address 100 SPY COURT MARKHAM Ontario, Canada (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 261044622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)